Research graph
References from Biotin‐Engineered Phenothiazine Photosensitizer Boosts Type I Photodynamic Therapy via Singlet‐Excited‐State Electron Transfer. Local targets link to admitted publications; unresolved targets remain external evidence.
Enhancing biosafety in photodynamic therapy: progress and perspectives
10.1039/d5cs00054h · 2025 · External reference
Clinical development and potential of photothermal and photodynamic therapies for cancer
10.1038/s41571-020-0410-2 · 2020 · External reference
Intramolecular Charge Transfer‐Enhanced BODIPY Photosensitizer in Photoinduced Electron Transfer and Its Application to Photoxidation under Mild Condition
10.1002/cjoc.201500494 · 2015 · External reference
Tactics to Improve the Photodynamic Therapeutic Efficacy Based on Nanomaterials
10.1002/cjoc.202401177 · 2025 · External reference
Smart molecular probes with controllable photophysical property for smart medicine
10.1002/smo.20240033 · 2024 · External reference
Photodynamic therapy based on organic small molecular fluorescent dyes
10.1016/j.cclet.2019.04.017 · 2019 · External reference
Recent progress in tumor photodynamic immunotherapy
10.1016/j.cclet.2020.02.007 · 2020 · External reference
Molecular Engineering of AIE‐Active Ionic Photosensitizer for Dual‐Organelle Targeted NIR‐II Phototheranostics
10.1002/adfm.202514187 · 2026 · External reference
A Type I/II Photosensitizer with Lysosome‐Targeting Capabilities Induces Immunogenic Cell Death in Cancer Cells to Enhance Tumor Immunotherapy
10.1021/acsnano.5c14676 · 2026 · External reference
Heterodimeric Photosensitizer as Radical Generators to Promoting Type I Photodynamic Conversion for Hypoxic Tumor Therapy
10.1002/adma.202410992 · 2025 · External reference
Synergistic Copper‐Coordination/Glutathione Reduction Drives an In Situ Type II‐to‐Type I Photodynamic Switch in Iridium‐Based Photosensitizer Nanocomposites for Potentiated Cancer Immunotherapy
10.1002/adma.202506349 · 2025 · External reference
A self‐reinforced activatable photosensitizer prodrug enabling synergistic photodynamic and chemotherapy
10.1002/smo.20240005 · 2024 · External reference
Photodynamic Therapy for the Treatment and Diagnosis of Cancer‐A Review of the Current Clinical Status
10.3389/fchem.2021.686303 · 2021 · External reference
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
10.1039/b915149b · 2011 · External reference
Recent progress of molecular design in organic type I photosensitizers
10.1002/smll.202501911 · 2025 · External reference
Recent advances in type I organic photosensitizers for efficient photodynamic therapy for overcoming tumor hypoxia
10.1039/d3tb00545c · 2023 · External reference
New guidelines and definitions for type I photodynamic therapy
10.1039/d1cs01079d · 2025 · External reference
Near‐infrared light‐initiated molecular superoxide radical generator: rejuvenating photodynamic therapy against hypoxic tumors
10.1021/jacs.8b08658 · 2018 · External reference
Type‐I Supramolecular Photosensitizer Enables GSH Depletion by Hydrogen Atom Transfer
10.1021/jacs.5c14257 · 2025 · External reference
Rational Design of Type‐I Photodynamic Agents
10.1002/anie.202509416 · 2025 · External reference
Preparation of ENBSe‐based photoredox catalysts for O2‐independent phototherapy in living systems
10.1038/s41596-025-01328-4 · 2026 · External reference
The Current Advances in Design Strategy (Indirect Strategy and Direct Strategy) for Type‐I Photosensitizers
10.1002/advs.202413365 · 2025 · External reference
An emerging molecular design approach to heavy‐atom‐free photosensitizers for enhanced photodynamic therapy under hypoxia
10.1021/jacs.9b09220 · 2019 · External reference
Molecular engineering to boost AIE‐active free radical photogenerators and enable high‐performance photodynamic therapy under hypoxia
10.1002/adfm.202002057 · 2020 · External reference
Rational design of a meso phosphate‐substituted pyronin as a type I photosensitizer for photodynamic therapy
10.1039/d2cc02124b · 2022 · External reference
BODIPY‐based photodynamic agents for exclusively generating superoxide radical over singlet oxygen
10.1002/anie.202106748 · 2021 · External reference
Acceptor‐engineering tailored type‐I photosensitizer with aggregation‐induced NIR‐II emission for cancer multimodal phototheranostics
10.1007/s11426-024-1980-x · 2024 · External reference
Integration of TADF photosensitizer as “electron pump” and BSA as “electron reservoir” for boosting type I photodynamic therapy
10.1021/jacs.3c01042 · 2023 · External reference
Supramolecular photodynamic agents for simultaneous oxidation of NADH and generation of superoxide radical
10.1038/s41467-022-33924-3 · 2022 · External reference
Near‐infrared self‐assembled hydroxyl radical generator based on photoinduced cascade electron transfer for hypoxic tumor phototherapy
10.1002/adma.202305163 · 2023 · External reference
Unveiling the power of dark state photocages: an efficient pathway to triplet state under near‐infrared light irradiation
10.1002/anie.202504670 · 2025 · External reference
Urea‐Bond Scission Induced by Therapeutic Ultrasound for Biofunctional Molecule Release
10.1021/jacs.2c03669 · 2022 · External reference
A Brain‐Targeting NIR‐II Polymeric Phototheranostic Nanoplatform toward Orthotopic Drug‐Resistant Glioblastoma
10.1021/acs.nanolett.4c05470 · 2025 · External reference
Ferrous iron metabolism modulator for immune stress regulation and its application in skin allograft models
10.1021/jacs.5c04246 · 2025 · External reference
From Fluorescent Probes to the Theranostics Platform
10.1002/cjoc.202200122 · 2022 · External reference
A proximity tagging strategy utilizing an activated aldehyde group as the active site
10.1016/j.cclet.2024.110127 · 2025 · External reference
Smart nanoassembly enabling activatable NIR fluorescence and ROS generation with enhanced tumor penetration for imaging‐guided photodynamic therapy
10.1002/adma.202404296 · 2024 · External reference
Biotinylated Bilirubin Nanoparticles as a Tumor Microenvironment‐Responsive Drug Delivery System for Targeted Cancer Therapy
10.1002/advs.201800017 · 2018 · External reference
Tandem Targeting and Dual Aggregation of an AIEgen for Enhanced Near‐Infrared Fluorescence Imaging of Tumors
10.1021/jacs.4c10606 · 2024 · External reference
Click Biotinylation of PLGA Template for Biotin Receptor Oriented Delivery of Doxorubicin Hydrochloride in 4T1 Cell‐Induced Breast Cancer
10.1021/acs.molpharmaceut.7b00310 · 2017 · External reference
Toward Precise Antitumoral Photodynamic Therapy Using a Dual Receptor‐Mediated Bioorthogonal Activation Approach
10.1002/anie.202214473 · 2023 · External reference
A Multivalent Targeting Strategy for Developing Reactive Oxygen Species‐Activated Tumor‐Seeking Probe to Guide Precise Surgical Resection
10.1002/anie.202510441 · 2025 · External reference
Self‐Assembled Nano‐CT Contrast Agent Leveraging Size Aggregation for Improved In Vivo Tumor CT Imaging
10.1002/adma.202309789 · 2024 · External reference
An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers
10.1038/s41467-022-29862-9 · 2022 · External reference
A 690‐nm‐excitable type I & II photosensitizer based on biotinylation of verteporfin for photodynamic therapy of deep‐seated orthotopic breast tumors
10.1016/j.cclet.2024.110315 · 2025 · External reference
Reprogramming photodynamic therapy from apoptosis to pyroptosis via symmetric hydrophobic editing of methylene blue
2026 · External reference
Outcomes of folic acid esterification upon the properties of hydrophilic phenothiazinium dyes: New photosensitizers for antimicrobial photodynamic therapy
10.1016/j.jphotochem.2024.115500 · 2024 · External reference
Molecular engineering to boost AIE‐active free radical photogenerators and enable high‐performance photodynamic therapy under hypoxia
10.1002/adfm.202002057 · ExternalCitation · doi-reference
Molecular Engineering of AIE‐Active Ionic Photosensitizer for Dual‐Organelle Targeted NIR‐II Phototheranostics
10.1002/adfm.202514187 · ExternalCitation · doi-reference
Near‐infrared self‐assembled hydroxyl radical generator based on photoinduced cascade electron transfer for hypoxic tumor phototherapy
10.1002/adma.202305163 · ExternalCitation · doi-reference
Self‐Assembled Nano‐CT Contrast Agent Leveraging Size Aggregation for Improved In Vivo Tumor CT Imaging
10.1002/adma.202309789 · ExternalCitation · doi-reference
Smart nanoassembly enabling activatable NIR fluorescence and ROS generation with enhanced tumor penetration for imaging‐guided photodynamic therapy
10.1002/adma.202404296 · ExternalCitation · doi-reference
Heterodimeric Photosensitizer as Radical Generators to Promoting Type I Photodynamic Conversion for Hypoxic Tumor Therapy
10.1002/adma.202410992 · ExternalCitation · doi-reference
Synergistic Copper‐Coordination/Glutathione Reduction Drives an In Situ Type II‐to‐Type I Photodynamic Switch in Iridium‐Based Photosensitizer Nanocomposites for Potentiated Cancer Immunotherapy
10.1002/adma.202506349 · ExternalCitation · doi-reference
Biotinylated Bilirubin Nanoparticles as a Tumor Microenvironment‐Responsive Drug Delivery System for Targeted Cancer Therapy
10.1002/advs.201800017 · ExternalCitation · doi-reference
The Current Advances in Design Strategy (Indirect Strategy and Direct Strategy) for Type‐I Photosensitizers
10.1002/advs.202413365 · ExternalCitation · doi-reference
BODIPY‐based photodynamic agents for exclusively generating superoxide radical over singlet oxygen
10.1002/anie.202106748 · ExternalCitation · doi-reference
Toward Precise Antitumoral Photodynamic Therapy Using a Dual Receptor‐Mediated Bioorthogonal Activation Approach
10.1002/anie.202214473 · ExternalCitation · doi-reference
Unveiling the power of dark state photocages: an efficient pathway to triplet state under near‐infrared light irradiation
10.1002/anie.202504670 · ExternalCitation · doi-reference
Rational Design of Type‐I Photodynamic Agents
10.1002/anie.202509416 · ExternalCitation · doi-reference
A Multivalent Targeting Strategy for Developing Reactive Oxygen Species‐Activated Tumor‐Seeking Probe to Guide Precise Surgical Resection
10.1002/anie.202510441 · ExternalCitation · doi-reference
Intramolecular Charge Transfer‐Enhanced BODIPY Photosensitizer in Photoinduced Electron Transfer and Its Application to Photoxidation under Mild Condition
10.1002/cjoc.201500494 · ExternalCitation · doi-reference
From Fluorescent Probes to the Theranostics Platform
10.1002/cjoc.202200122 · ExternalCitation · doi-reference
Tactics to Improve the Photodynamic Therapeutic Efficacy Based on Nanomaterials
10.1002/cjoc.202401177 · ExternalCitation · doi-reference
Recent progress of molecular design in organic type I photosensitizers
10.1002/smll.202501911 · ExternalCitation · doi-reference
A self‐reinforced activatable photosensitizer prodrug enabling synergistic photodynamic and chemotherapy
10.1002/smo.20240005 · ExternalCitation · doi-reference
Smart molecular probes with controllable photophysical property for smart medicine
10.1002/smo.20240033 · ExternalCitation · doi-reference
Acceptor‐engineering tailored type‐I photosensitizer with aggregation‐induced NIR‐II emission for cancer multimodal phototheranostics
10.1007/s11426-024-1980-x · ExternalCitation · doi-reference
Photodynamic therapy based on organic small molecular fluorescent dyes
10.1016/j.cclet.2019.04.017 · ExternalCitation · doi-reference
Recent progress in tumor photodynamic immunotherapy
10.1016/j.cclet.2020.02.007 · ExternalCitation · doi-reference
A proximity tagging strategy utilizing an activated aldehyde group as the active site
10.1016/j.cclet.2024.110127 · ExternalCitation · doi-reference
A 690‐nm‐excitable type I & II photosensitizer based on biotinylation of verteporfin for photodynamic therapy of deep‐seated orthotopic breast tumors
10.1016/j.cclet.2024.110315 · ExternalCitation · doi-reference
Outcomes of folic acid esterification upon the properties of hydrophilic phenothiazinium dyes: New photosensitizers for antimicrobial photodynamic therapy
10.1016/j.jphotochem.2024.115500 · ExternalCitation · doi-reference
Click Biotinylation of PLGA Template for Biotin Receptor Oriented Delivery of Doxorubicin Hydrochloride in 4T1 Cell‐Induced Breast Cancer
10.1021/acs.molpharmaceut.7b00310 · ExternalCitation · doi-reference
A Brain‐Targeting NIR‐II Polymeric Phototheranostic Nanoplatform toward Orthotopic Drug‐Resistant Glioblastoma
10.1021/acs.nanolett.4c05470 · ExternalCitation · doi-reference
A Type I/II Photosensitizer with Lysosome‐Targeting Capabilities Induces Immunogenic Cell Death in Cancer Cells to Enhance Tumor Immunotherapy
10.1021/acsnano.5c14676 · ExternalCitation · doi-reference
Urea‐Bond Scission Induced by Therapeutic Ultrasound for Biofunctional Molecule Release
10.1021/jacs.2c03669 · ExternalCitation · doi-reference
Integration of TADF photosensitizer as “electron pump” and BSA as “electron reservoir” for boosting type I photodynamic therapy
10.1021/jacs.3c01042 · ExternalCitation · doi-reference
Tandem Targeting and Dual Aggregation of an AIEgen for Enhanced Near‐Infrared Fluorescence Imaging of Tumors
10.1021/jacs.4c10606 · ExternalCitation · doi-reference
Ferrous iron metabolism modulator for immune stress regulation and its application in skin allograft models
10.1021/jacs.5c04246 · ExternalCitation · doi-reference
Type‐I Supramolecular Photosensitizer Enables GSH Depletion by Hydrogen Atom Transfer
10.1021/jacs.5c14257 · ExternalCitation · doi-reference
Near‐infrared light‐initiated molecular superoxide radical generator: rejuvenating photodynamic therapy against hypoxic tumors
10.1021/jacs.8b08658 · ExternalCitation · doi-reference
An emerging molecular design approach to heavy‐atom‐free photosensitizers for enhanced photodynamic therapy under hypoxia
10.1021/jacs.9b09220 · ExternalCitation · doi-reference
An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers
10.1038/s41467-022-29862-9 · ExternalCitation · doi-reference
Supramolecular photodynamic agents for simultaneous oxidation of NADH and generation of superoxide radical
10.1038/s41467-022-33924-3 · ExternalCitation · doi-reference
Clinical development and potential of photothermal and photodynamic therapies for cancer
10.1038/s41571-020-0410-2 · ExternalCitation · doi-reference
Preparation of ENBSe‐based photoredox catalysts for O2‐independent phototherapy in living systems
10.1038/s41596-025-01328-4 · ExternalCitation · doi-reference
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
10.1039/b915149b · ExternalCitation · doi-reference
New guidelines and definitions for type I photodynamic therapy
10.1039/d1cs01079d · ExternalCitation · doi-reference
Rational design of a meso phosphate‐substituted pyronin as a type I photosensitizer for photodynamic therapy
10.1039/d2cc02124b · ExternalCitation · doi-reference
Recent advances in type I organic photosensitizers for efficient photodynamic therapy for overcoming tumor hypoxia
10.1039/d3tb00545c · ExternalCitation · doi-reference
Enhancing biosafety in photodynamic therapy: progress and perspectives
10.1039/d5cs00054h · ExternalCitation · doi-reference
Photodynamic Therapy for the Treatment and Diagnosis of Cancer‐A Review of the Current Clinical Status
10.3389/fchem.2021.686303 · ExternalCitation · doi-reference
